Technical Analysis for ALBT - Avalon GloboCare Corp.

Grade Last Price % Change Price Change
F 0.32 5.79% 0.02
ALBT closed up 5.79 percent on Thursday, March 28, 2024, on 2.74 times normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: Mar 28
*** please verify all earnings dates ***
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Up

Date Alert Name Type % Chg
20 DMA Resistance Bearish 0.00%
Shooting Star Candlestick Bearish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Doji - Bearish? Reversal 0.00%
Earnings Movers Other 0.00%
Wide Bands Range Expansion 0.00%
Gapped Up Strength 0.00%
Boomer Sell Setup Bearish Swing Setup 5.79%
Narrow Range Bar Range Contraction 5.79%
Inside Day Range Contraction 5.79%

   Recent Intraday Alerts

Alert Time
20 DMA Resistance about 8 hours ago
Rose Above 20 DMA about 8 hours ago
2x Volume Pace about 8 hours ago
1.5x Volume Pace about 8 hours ago
3x Volume Pace about 8 hours ago

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Avalon GloboCare Corp. is a clinical-stage, vertically integrated, leading CellTech bio-developer dedicated to advancing and empowering innovative, transformative immune effector cell therapy, exosome technology, as well as COVID-19 related diagnostics and therapeutics. Avalon also provides strategic advisory and outsourcing services to facilitate and enhance its clients' growth and development, as well as competitiveness in healthcare and CellTech industry markets. Through its subsidiary structure with unique integration of verticals from innovative R&D to automated bioproduction and accelerated clinical development, Avalon is establishing a leading role in the fields of cellular immunotherapy (including CAR-T/NK), exosome technology (ACTEX™), and regenerative therapeutics.
Classification

Sector: Healthcare
Industry: Medical Care
Keywords: Medicine Clinical Medicine Immunotherapy Cell Therapy Exosome Bioproduction Vesicles

Is ALBT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.44
52 Week Low 0.25
Average Volume 179,709
200-Day Moving Average 0.79
50-Day Moving Average 0.38
20-Day Moving Average 0.35
10-Day Moving Average 0.32
Average True Range 0.03
RSI (14) 39.39
ADX 36.58
+DI 15.73
-DI 24.98
Chandelier Exit (Long, 3 ATRs) 0.35
Chandelier Exit (Short, 3 ATRs) 0.35
Upper Bollinger Bands 0.44
Lower Bollinger Band 0.27
Percent B (%b) 0.29
BandWidth 45.61
MACD Line -0.03
MACD Signal Line -0.02
MACD Histogram -0.0035
Fundamentals Value
Market Cap 3.52 Million
Num Shares 11 Million
EPS -0.93
Price-to-Earnings (P/E) Ratio -0.34
Price-to-Sales 4.16
Price-to-Book 7.51
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.39
Resistance 3 (R3) 0.40 0.38 0.38
Resistance 2 (R2) 0.38 0.36 0.38 0.38
Resistance 1 (R1) 0.35 0.35 0.34 0.34 0.37
Pivot Point 0.33 0.33 0.33 0.33 0.33
Support 1 (S1) 0.30 0.31 0.30 0.30 0.27
Support 2 (S2) 0.28 0.30 0.28 0.26
Support 3 (S3) 0.25 0.28 0.26
Support 4 (S4) 0.25